Elevation of Sema4A implicates Th cell skewing and the efficacy of IFN-β therapy in multiple sclerosis.
Nakatsuji Y, Okuno T, Moriya M, Sugimoto T, Kinoshita M, Takamatsu H, Nojima S, Kimura T, Kang S, Ito D, Nakagawa Y, Toyofuku T, Takata K, Nakano M, Kubo M, Suzuki S, Matsui-Hasumi A, Uto-Konomi A, Ogata A, Mochizuki H, Sakoda S, Kumanogoh A.
Nakatsuji Y, et al. Among authors: sugimoto t.
J Immunol. 2012 May 15;188(10):4858-65. doi: 10.4049/jimmunol.1102023. Epub 2012 Apr 9.
J Immunol. 2012.
PMID: 22491253